Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer

Clinical trial NCT00366457 · COMPLETED

Trial details

NCT number: NCT00366457
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Adenocarcinoma of the Pancreas

Start date: 2006-08-01
Primary completion: 2008-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.